SAN FRANCISCO--(BUSINESS WIRE)--Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around a newly identified class of enzymes to target Parkinson’s disease ...

Bad Ice Cream Triple Scoop features remasters of three different games in an “ultimate, definitive collection”. Expect every ...

Shovel Knight Dig developer Nitrome has announced Mouse Work, a party game for Switch 2 for up to four players that utilizes the hardware’s mouse controls. A release date was not announced. Mouse Work ...

Nitrome has announced plans to bring Bad Ice-Cream Resort to Switch. No release date has been set and a Kickstarter will be launching soon. You can check out the debut trailer for Bad Ice-Cream Resort ...

For some of us, Flash games were one of the first introductions to the world of games - short, silly titles played in browsers around the world, often built by hobbyists with a bright idea and some ...

Situated in the heart of London's Silicon Roundabout, Nitrome's studio is not entirely what you would expect. While the capital's high-tech business hub conjures images of Google Glass-wearing hipster ...

Nitrome's delightful 2D action-puzzle platformer Bomb Chicken, previously released on the Switch eShop in July last year, will be receiving the physical treatment later this month. Limited Run Games ...

The UK developer Nitrome - the team behind Bomb Chicken and also the upcoming release Shovel Knight Dig - has revealed it once pitched a Sonic the Hedgehog game to Sega and was knocked back. According ...

SAN FRANCISCO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc. (formerly Nitrome Biosciences), a biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic ...

Players take on the role of adorable mice competing to earn Cheddar, the in-game currency, which can be used to unlock cosmetics like hats and bow ties for their mouse cursors. Whether you’re painting ...

SAN FRANCISCO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around its newly discovered class of enzymes to target ...